Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Reumatismo ; 70(2): 85-91, 2018 Jul 06.
Article in English | MEDLINE | ID: mdl-29976042

ABSTRACT

The aim was to explore possible correlations of antibodies to extractable nuclear antigens (ENA) with clinical manifestations and disease activity indices in systemic lupus erythematosus (SLE) patients. A total of 70 consecutive SLE patients (64 females) were included. Disease activity was assessed by SLE activity index (SLEDAI), and British Isles Lupus Assessment Group (BILAG). Anti-Ro/SSA correlated positively with, headache (r=0.24, p=0.04), blurring of vision (r=0.25, p=0.03) and SLEDAI (r=0.25, p=0.04) and negatively with C3 (r=-0.35, p=0.003). Anti-Ro/SSA correlated with anti La/SSB antibodies (r=0.69, p<0.001), but not with anti-DNA, anti-RNP and anti-Sm antibodies. Anti-La/SSB antibodies correlated with headache (r=0.26, p=0.03), SLEDAI (r=0.25, p=0.03) and negatively with C3 (r=-0.34, p=0.004). Anti-La/SSB did not correlate with anti-RNP or anti-Sm antibodies. Anti-Sm antibodies correlated with disease duration (r=0.34, p=0.003), 24 hours urinary proteins (r=0.31, p=0.008), SLEDAI (r=0.31, p=0.009), BILAG renal score (r=0.29, p=0.02) and negatively with age at onset (r=-0.27, p=0.02), WBCs (r=-0.29, p=0.014) and C4 (r=-0.25, p=0.049). In multivariate analyses, anti-Ro/SSA antibodies remained associated with headache, blurring of vision and C3 and anti-La/SSB antibodies remained associated with C3 and with headache. Anti-Sm antibodies were independently associated with disease duration and total SLEDAI scores, while anti-RNP antibodies remained significantly associated with BILAG mucocutaneous scores only. Antibodies to ENAs are associated with clinical aspects of SLE and may play a role in the assessment of disease activity. Insight into these ENAs may lead to new approaches to diagnostic testing, accurate evaluation of disease activity and lead to target approach for SLE.


Subject(s)
Antibodies, Antinuclear/blood , Autoantigens/immunology , Lupus Erythematosus, Systemic/immunology , Ribonucleoprotein, U1 Small Nuclear/immunology , Ribonucleoproteins/immunology , snRNP Core Proteins/immunology , Adult , Autoantigens/chemistry , Cross-Sectional Studies , Female , Humans , Lupus Erythematosus, Systemic/blood , Male , Middle Aged , Ribonucleoprotein, U1 Small Nuclear/chemistry , Ribonucleoproteins/chemistry , Severity of Illness Index , Solubility , Symptom Assessment , snRNP Core Proteins/chemistry , SS-B Antigen
2.
J Occup Rehabil ; 24(2): 370-81, 2014 Jun.
Article in English | MEDLINE | ID: mdl-23975061

ABSTRACT

BACKGROUND: Lumbar disc degeneration (LDD) is a process that begins early in life, contributing to the development of low back pain. LDD is a consequence of a variety of factors, and its etiology remains poorly understood. Objectives to investigate occupational and genetic risk factors inducing lumbar disc degeneration, and to evaluate the possible association of genetic polymorphisms of matrix metalloproteinase 3 (MMP-3) and vitamin D receptor (VDR) with the severity of LDD in an Egyptian population. SUBJECTS AND METHODS: A case control study involving 84 LDD and 60 controls was carried out. Five types of work related factors were investigated by questionnaire, complete neurological examination for all subjects and MRI for the cases. Polymerase chain reaction and restriction fragment length polymorphism methods were applied to detect polymorphisms in MMP-3 Promoter (-1,171 6A/5A) (rs 731236) and VDR-Apa (rs 35068180). RESULTS: We found that family history, back injury, smoking, high level of sitting, bending/twisting, physical workload, lifting, whole body vibration, mutant allele 5A of MMP-3 and mutant allele T of VDR were significantly associated with LDD (OR = 2.9, 3.1, 2.1, 11.1, 15.9, 11.7, 8.2, 12.6, 2.5 and 3.1 respectively, p < 0.05). Cases that carry allele 5A and/or allele T were associated with LDD severity. CONCLUSION: LDD is closely associated in occurrence and severity with occupational, environmental risk factors and susceptibility genes namely MMP-3, and VDR (ApaI). This study throws light on the importance of screening for early detection of susceptible individuals and disease prevention.


Subject(s)
Intervertebral Disc Degeneration/genetics , Lumbar Vertebrae , Matrix Metalloproteinase 3/genetics , Occupational Diseases/genetics , Receptors, Calcitriol/genetics , Adult , Back Injuries/complications , Case-Control Studies , Egypt , Female , Genetic Predisposition to Disease , Humans , Intervertebral Disc Degeneration/diagnosis , Intervertebral Disc Degeneration/epidemiology , Magnetic Resonance Imaging , Male , Middle Aged , Neurologic Examination , Occupational Diseases/diagnosis , Occupational Diseases/epidemiology , Physical Exertion , Polymorphism, Restriction Fragment Length , Posture , Promoter Regions, Genetic , Risk Factors , Severity of Illness Index , Smoking , Surveys and Questionnaires , Vibration
3.
Clin Immunol ; 135(1): 118-24, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20116334

ABSTRACT

The aim of the present study is to assess serum APRIL levels in SLE patients versus rheumatoid arthritis (RA) patients and normal control and to correlate serum APRIL levels in SLE patients with disease activity indices. Serum APRIL levels was measured in 40 SLE patients, 20 patients with RA and 20 healthy volunteers who served as control group. Disease activity in SLE patients was assessed by the British Isles Lupus Assessment Group (BILAG) index and SLE disease activity index (SLEDAI), and results were correlated with serum APRIL levels. Significantly higher serum APRIL levels was observed in SLE patients compared to RA patients and normal controls (p=0.003 and p < or = 0.001, respectively). Positive correlations were found between serum APRIL levels and total BILAG index (r=0.486 and p=0.001), BILAG musculoskeletal score (r=0.848 and p < or = 0.001) and BILAG cardiorespiratory score (r=0.326 and 0.04). Serum APRIL was higher in SLE patients compared to RA patients and normal control subjects and positively correlates with BILAG index and higher levels may be associated with musculoskeletal manifestations of the disease. APRIL antagonism could be a potential therapeutic target in SLE.


Subject(s)
Arthritis, Rheumatoid/immunology , Lupus Erythematosus, Systemic/immunology , Tumor Necrosis Factor Ligand Superfamily Member 13/immunology , Adult , Arthritis, Rheumatoid/blood , Case-Control Studies , Enzyme-Linked Immunosorbent Assay , Female , Humans , Lupus Erythematosus, Systemic/blood , Male , Severity of Illness Index , Statistics, Nonparametric , Tumor Necrosis Factor Ligand Superfamily Member 13/blood
SELECTION OF CITATIONS
SEARCH DETAIL